Clinical Trial: FIH Study to Evaluate Safety, Tolerability, PK, PD & Preliminary Efficacy of AT03-65 With Advanced Solid Tumors

U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT06809114) titled 'FIH Study to Evaluate Safety, Tolerability, PK, PD & Preliminary Efficacy of AT03-65 With Advanced Solid Tumors' on Jan. 24.

Brief Summary: A Phase I, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of AT03-65 in Adults with Advanced Solid Tumors

Study Start Date: April, 2025

Study Type: INTERVENTIONAL

Condition: Solid Tumor

Intervention: DRUG: AT03-65

Treatment will continue until disease progression, unacceptable toxicity, subject withdrawal of consent or death.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Axcynsis Therapeutics Pte Ltd

Disclaimer: ...